Entheon Biomedical Current Valuation vs. Gross Profit
| ENTBF Stock | USD 0.12 0.03 33.33% |
For Entheon Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Entheon Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Entheon Biomedical Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Entheon Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Entheon Biomedical Corp over time as well as its relative position and ranking within its peers.
Entheon |
Entheon Biomedical Corp Gross Profit vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Entheon Biomedical's current stock value. Our valuation model uses many indicators to compare Entheon Biomedical value to that of its competitors to determine the firm's financial worth. Entheon Biomedical Corp is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in gross profit category among its peers fabricating about 0.01 of Gross Profit per Current Valuation. The ratio of Current Valuation to Gross Profit for Entheon Biomedical Corp is roughly 122.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Entheon Biomedical's earnings, one of the primary drivers of an investment's value.Entheon Current Valuation vs. Competition
Entheon Biomedical Corp is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Biotechnology industry is currently estimated at about 10.55 Billion. Entheon Biomedical adds roughly 1.12 Million in current valuation claiming only tiny portion of stocks in Biotechnology industry.
Entheon Gross Profit vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Entheon Biomedical |
| = | 1.12 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Entheon Biomedical |
| = | 9.13 K |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Entheon Gross Profit Comparison
Entheon Biomedical is currently under evaluation in gross profit category among its peers.
Entheon Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Entheon Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Entheon Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Entheon Biomedical's change in net profit over the period of time. It can combine multiple indicators of Entheon Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. ENTHEON BIOMEDICAL operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Entheon Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Entheon Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Entheon Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Entheon Biomedical's important profitability drivers and their relationship over time.
Use Entheon Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entheon Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entheon Biomedical will appreciate offsetting losses from the drop in the long position's value.Entheon Biomedical Pair Trading
Entheon Biomedical Corp Pair Trading Analysis
The ability to find closely correlated positions to Entheon Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entheon Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entheon Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entheon Biomedical Corp to buy it.
The correlation of Entheon Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entheon Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entheon Biomedical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entheon Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Entheon Biomedical position
In addition to having Entheon Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aircraft Thematic Idea Now
Aircraft
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Entheon OTC Stock
To fully project Entheon Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Entheon Biomedical Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Entheon Biomedical's income statement, its balance sheet, and the statement of cash flows.